• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面修饰的含聚(β 氨基酸酯)纳米粒用于质粒 DNA 的递送。

Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

机构信息

Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.

出版信息

J Control Release. 2012 Nov 28;164(1):41-8. doi: 10.1016/j.jconrel.2012.09.020. Epub 2012 Oct 5.

DOI:10.1016/j.jconrel.2012.09.020
PMID:23041278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3625648/
Abstract

The use of biodegradable polymers provides a potentially safe and effective alternative to viral and liposomal vectors for the delivery of plasmid DNA to cells for gene therapy applications. In this work we describe the formulation of a novel nanoparticle (NP) system containing a blend of poly(lactic-co-glycolic acid) and a representative poly(beta-amino) ester (PLGA and PBAE respectively) for use as gene delivery vehicles. Particles of different weight/weight (wt/wt) ratios of the two polymers were characterized for size, morphology, plasmid DNA (pDNA) loading and surface charge. NPs containing PBAE were more effective at cellular internalization and transfection (COS-7 and CFBE41o-) than NPs lacking the PBAE polymer. However, along with these delivery benefits, PBAE exhibited cytotoxic effects that presented an engineering challenge. Surface coating of these blended particles with the cell-penetrating peptides (CPPs) mTAT, bPrPp and MPG via a PEGylated phospholipid linker (DSPE-PEG2000) resulted in NPs that reduced surface charge and cellular toxicity to levels comparable with NPs formulated with only PLGA. Additionally, these coated nanoparticles showed an improvement in pDNA loading, intracellular uptake and transfection efficiency, when compared to NPs lacking the surface coating. Although all particles with a CPP coating outperformed unmodified NPs, respectively, bPrPp and MPG coating resulted in 3 and 4.5× more pDNA loading than unmodified particles and approximately an order of magnitude improvement on transfection efficiency in CFBE41o- cells. These results demonstrate that surface-modified PBAE containing NPs are a highly effective and minimally toxic platform for pDNA delivery.

摘要

可生物降解聚合物的使用为将质粒 DNA 递送到细胞中用于基因治疗应用的病毒和脂质体载体提供了一种潜在的安全有效的替代方法。在这项工作中,我们描述了一种新型纳米颗粒 (NP) 系统的配方,该系统包含聚(乳酸-共-乙醇酸)和代表性的聚(β-氨基)酯(PLGA 和 PBAE 分别)的混合物,用作基因传递载体。对不同重量/重量 (wt/wt) 比的两种聚合物的粒子进行了大小、形态、质粒 DNA (pDNA) 负载和表面电荷的表征。含有 PBAE 的 NPs 比不含 PBAE 聚合物的 NPs 更有效地进行细胞内化和转染(COS-7 和 CFBE41o-)。然而,除了这些传递益处之外,PBAE 还表现出细胞毒性作用,这给工程带来了挑战。通过 PEG 化磷脂链接(DSPE-PEG2000)将这些混合粒子的表面用穿透肽 (CPP) mTAT、bPrPp 和 MPG 进行涂层,得到的 NPs 降低了表面电荷和细胞毒性,使其与仅用 PLGA 配制的 NPs 相当。此外,与没有表面涂层的 NPs 相比,这些涂覆的纳米颗粒在 pDNA 负载、细胞内摄取和转染效率方面表现出改善。尽管所有带有 CPP 涂层的粒子的性能均优于未修饰的 NPs,但 bPrPp 和 MPG 涂层分别使 pDNA 负载增加了 3 倍和 4.5 倍,并且在 CFBE41o-细胞中的转染效率提高了约一个数量级。这些结果表明,表面修饰的含 PBAE 的 NPs 是一种高效且毒性最小的 pDNA 传递平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/74d30dcc924b/nihms412710f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/8a246d4a823b/nihms412710f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/24580f316e85/nihms412710f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/fede48ad7ce1/nihms412710f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/0a2ed72c1dec/nihms412710f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/34ac3e18b9c1/nihms412710f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/ccf60be30f8e/nihms412710f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/74d30dcc924b/nihms412710f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/8a246d4a823b/nihms412710f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/24580f316e85/nihms412710f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/fede48ad7ce1/nihms412710f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/0a2ed72c1dec/nihms412710f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/34ac3e18b9c1/nihms412710f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/ccf60be30f8e/nihms412710f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd9/3625648/74d30dcc924b/nihms412710f7.jpg

相似文献

1
Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.表面修饰的含聚(β 氨基酸酯)纳米粒用于质粒 DNA 的递送。
J Control Release. 2012 Nov 28;164(1):41-8. doi: 10.1016/j.jconrel.2012.09.020. Epub 2012 Oct 5.
2
Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety.用于增强基因递送和生物安全性的谷胱甘肽杂化聚(β-氨基酯)-质粒纳米颗粒
J Adv Res. 2024 Aug 2. doi: 10.1016/j.jare.2024.07.038.
3
Synthesis and characterization of poly (β-amino ester) polyplex nanocarrier with high encapsulation and uptake efficiency: impact of extracellular conditions.具有高包封率和摄取效率的聚(β-氨基酯)多聚体纳米载体的合成与表征:细胞外条件的影响
Nanomedicine (Lond). 2025 Jan;20(2):125-139. doi: 10.1080/17435889.2024.2440307. Epub 2024 Dec 16.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Poly(d,l-lactide--glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells.包裹阿霉素的聚(d,l-丙交酯-乙交酯)纳米颗粒用于改善胆管癌及耐药细胞的治疗
ACS Appl Bio Mater. 2025 Jun 18. doi: 10.1021/acsabm.5c00628.
6
Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs.无配体可生物降解的聚(β-氨基酯)纳米粒用于靶向递送至肺部的 mRNA 的系统给药。
Biomaterials. 2025 Feb;313:122753. doi: 10.1016/j.biomaterials.2024.122753. Epub 2024 Aug 20.
7
Design of paclitaxel-loaded PLGA nanoparticles assisted by compatibility modeling.基于相容性建模辅助的紫杉醇载药聚乳酸-羟基乙酸共聚物纳米粒的设计
Int J Pharm. 2025 Sep 15;682:125985. doi: 10.1016/j.ijpharm.2025.125985. Epub 2025 Jul 21.
8
In vitro and in vivo delivery of mRNA to joint cells using polymeric nanoparticles.使用聚合物纳米颗粒在体外和体内将mRNA递送至关节细胞。
Acta Biomater. 2025 Jun 24. doi: 10.1016/j.actbio.2025.06.039.
9
Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.可生物降解微球的合理设计、制备、表征和体外测试,该微球可在 HepG2 肝细胞中产生靶向和持续的转基因表达。
J Drug Target. 2011 Jul;19(6):393-408. doi: 10.3109/1061186X.2010.504263. Epub 2010 Aug 3.
10
DS-Modified Paeoniflorin pH-Responsive Lipid-Polymer Hybrid Nanoparticles for Targeted Macrophage Polarization in a Rat Model of Rheumatoid Arthritis.用于类风湿性关节炎大鼠模型中靶向巨噬细胞极化的DS修饰芍药苷pH响应性脂质-聚合物杂化纳米颗粒
Int J Nanomedicine. 2025 Jul 12;20:8967-8992. doi: 10.2147/IJN.S516434. eCollection 2025.

引用本文的文献

1
Systemic in utero gene editing as a treatment for cystic fibrosis.子宫内全身基因编辑作为囊性纤维化的一种治疗方法。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2418731122. doi: 10.1073/pnas.2418731122. Epub 2025 Jun 10.
2
Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment.合成聚合物辅助反义寡核苷酸递送:精准疾病治疗的靶向方法
Beilstein J Nanotechnol. 2025 Mar 27;16:435-463. doi: 10.3762/bjnano.16.34. eCollection 2025.
3
Furan-rich, biobased transfection agents as potential oligomeric candidates for intracellular plasmid DNA delivery.

本文引用的文献

1
Polymeric Materials for Gene Delivery and DNA Vaccination.用于基因递送和DNA疫苗接种的聚合物材料
Adv Mater. 2009 Feb 23;21(8):847-867. doi: 10.1002/adma.200801478. Epub 2008 Dec 4.
2
Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.八功能 PLGA 纳米粒用于肿瘤的靶向和高效 siRNA 递送。
Biomaterials. 2012 Jan;33(2):583-91. doi: 10.1016/j.biomaterials.2011.09.061. Epub 2011 Oct 19.
3
Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
富含呋喃的生物基转染剂作为细胞内质粒DNA递送的潜在低聚物候选物。
RSC Adv. 2024 Oct 15;14(44):32637-32647. doi: 10.1039/d4ra05978f. eCollection 2024 Oct 9.
4
Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.聚合物载体用于核酸递送:增强治疗效果和细胞摄取。
Recent Adv Drug Deliv Formul. 2024;18(4):276-293. doi: 10.2174/0126673878324536240805060143.
5
Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation.用于F508del囊性纤维化跨膜传导调节因子突变位点特异性基因组编辑的下一代三链形成肽核酸
J Cyst Fibros. 2025 Jan;24(1):142-148. doi: 10.1016/j.jcf.2024.07.009. Epub 2024 Aug 5.
6
Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials.基于天然和合成生物材料的微纳米药物递送系统的最新进展
Polymers (Basel). 2023 Nov 28;15(23):4563. doi: 10.3390/polym15234563.
7
Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.非病毒 mRNA 递药材料的研究进展及其作为黑素瘤治疗疫苗的应用
ACS Appl Bio Mater. 2024 Aug 19;7(8):4894-4913. doi: 10.1021/acsabm.3c00721. Epub 2023 Nov 6.
8
Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.用于高效递送抗miRNA肽核酸(PNA)和miRNA模拟物的阳离子杯[4]芳烃载体
Pharmaceutics. 2023 Aug 10;15(8):2121. doi: 10.3390/pharmaceutics15082121.
9
Biomaterial-based gene therapy.基于生物材料的基因治疗。
MedComm (2020). 2023 Jun 3;4(3):e259. doi: 10.1002/mco2.259. eCollection 2023 Jun.
10
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.作为治疗基因的非病毒载体的纳米载体增强肺部递送的机制和挑战。
J Control Release. 2022 Dec;352:970-993. doi: 10.1016/j.jconrel.2022.10.061. Epub 2022 Nov 16.
新型适体-纳米颗粒生物缀合物增强了抗癌药物在体外向 MUC1 阳性癌细胞的递送。
PLoS One. 2011;6(9):e24077. doi: 10.1371/journal.pone.0024077. Epub 2011 Sep 1.
4
Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies.多功能非病毒基因载体的设计以克服生理屏障:困境与策略。
Int J Pharm. 2012 May 1;427(1):3-20. doi: 10.1016/j.ijpharm.2011.07.013. Epub 2011 Jul 22.
5
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.阴道给药后表面修饰的 PLGA 纳米粒的体内分布。
J Control Release. 2011 Dec 10;156(2):258-64. doi: 10.1016/j.jconrel.2011.06.036. Epub 2011 Jul 8.
6
Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.利用靶向配体和细胞穿透肽之间的协同作用增强 siRNA 向细胞内的递送。
Biomaterials. 2011 Sep;32(26):6194-203. doi: 10.1016/j.biomaterials.2011.04.053. Epub 2011 Jun 12.
7
Gene and cell therapy for cystic fibrosis: from bench to bedside.囊性纤维化的基因和细胞治疗:从基础到临床。
J Cyst Fibros. 2011 Jun;10 Suppl 2:S114-28. doi: 10.1016/S1569-1993(11)60017-9.
8
Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.聚乙二醇化脂质体的双配体修饰显示出更好的细胞选择性和高效的基因传递。
J Control Release. 2011 Jul 30;153(2):141-8. doi: 10.1016/j.jconrel.2011.03.012. Epub 2011 Apr 5.
9
Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.工程化 PLGA 纳米粒:癌症治疗中的一种新兴递药工具。
Crit Rev Ther Drug Carrier Syst. 2011;28(1):1-45. doi: 10.1615/critrevtherdrugcarriersyst.v28.i1.10.
10
Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis.经阳离子脂质体修饰的 Tat 肽通过温度依赖性和胞吞小窝介导的内吞作用增强基因转染效率。
J Control Release. 2011 Jun 10;152(2):278-85. doi: 10.1016/j.jconrel.2011.02.004. Epub 2011 Feb 21.